Morling Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Morling Financial Advisors's LLY Position: Q3 2026 in Review
Morling Financial Advisors sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 236 shares — an estimated $283K sold.
Morling Financial Advisors first reported a position in LLY in Q4 2021 and held it in 17 quarters. The position peaked at $468K in Q1 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Morling Financial Advisors reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
- Morling Financial Advisors sold 236 Eli Lilly shares in Q3 2026, an estimated $283K.
- Morling Financial Advisors first reported a position in Eli Lilly in Q4 2021 and held it in 17 quarters.
- Morling Financial Advisors's Eli Lilly position peaked at $468K in Q1 2025.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Morling Financial Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.